Suven Life Sciences shares gained on Wednesday after has secured product patent from South Korea (10-1386354), one product patent from China (CN102639526) and one product patent from Canada (CA 2737282) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029, 2029 and 2031 respectively.

Shares of the company are trading at Rs 164.80, up Rs 3.4, or 2.11% at the Bombay Stock Exchange (BSE) on Wednesday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 168.95 and low of Rs 157.15. The total volume of shares traded at the BSE is 431,455.